tiprankstipranks
Trending News
More News >
20 Microns Limited (IN:20MICRONS)
:20MICRONS
India Market

20 Microns Limited (20MICRONS) AI Stock Analysis

Compare
4 Followers

Top Page

IN:20MICRONS

20 Microns Limited

(20MICRONS)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 5.2)
,
Neutral 62 (OpenAI - 5.2)
,
Neutral 62 (OpenAI - 5.2)
,
Neutral 62 (OpenAI - 5.2)
,
Neutral 62 (OpenAI - 5.2)
Rating:62Neutral
Price Target:
₹161.00
▼(-18.87% Downside)
Action:DowngradedDate:03/17/26
The score is supported primarily by strong profitability metrics and a stable balance sheet, plus a reasonable P/E valuation. It is held back by weak cash flow (negative free cash flow growth and weaker cash conversion) and bearish technicals with the price below key moving averages and negative MACD.
Positive Factors
High profitability margins
Sustained high gross and EBIT margins indicate structural pricing power from product mix and cost control. Over 2–6 months this supports reinvestment capacity and resilience to input swings, enabling funding for R&D, quality control and margin-preserving commercialization of value-added grades.
Conservative balance sheet and strong ROE
Prudent leverage and a strong equity base provide financial flexibility and lower solvency risk. A 14.5% ROE signals effective capital deployment, allowing the company to fund organic growth or absorb shocks without excessive refinancing, supporting durable operations and strategic optionality.
Specialized, value-added product portfolio and diversified end-markets
Engineering and surface-treatment capabilities create specification-driven products that command better realizations and foster repeat, stickier customer relationships. Broad end-market exposure reduces single-sector dependency and supports steady demand over multi-month horizons.
Negative Factors
Weak free cash flow and cash conversion
Material deterioration in free cash flow and modest cash conversion imply earnings do not fully translate into spendable cash. Persisting over months, this constrains dividend capacity, debt reduction and discretionary investment, increasing reliance on external financing or trimming growth projects.
Substantial capital expenditures pressure cash flows
Ongoing high capex to support capacity or quality improvements can be strategic, but sustained elevated investment that outpaces operating cash generation risks eroding liquidity and return on invested capital unless new capacity yields commensurate margin or volume gains.
Exposure to cyclical downstream demand
Revenue and pricing sensitivity to industrial and construction cycles creates structural earnings volatility. Over a 2–6 month horizon, downturns in key end-markets can depress volumes and realizations, testing margin sustainability and working capital management.

20 Microns Limited (20MICRONS) vs. iShares MSCI India ETF (INDA)

20 Microns Limited Business Overview & Revenue Model

Company Description20 Microns Limited engages in the industrial micronized minerals and specialty chemicals businesses in India. The company offers industrial minerals, such as ground calcium carbonate, dolomite, hydrous and calcined kaolins, talcs, natural barytes, silica/quartz, muscovite mica, feldspar/nepheline syenite, diatomaceous and siliceoaus earth, bentonite and attapulgite, and natural and synthetic red oxide. It also provides functional additives and specialties, including white/buff and colored, rutile TiO2, white pigment opacifiers, synthetic barium sulphate, micronized wax, anti-blocking additives, rheological additives, matting agents, inorganic thickeners, flame retardants, calcium oxide desiccant, activators for rubber, high aspect ratio talc, sub-micron CaCO3, and decorative colored quartz sand; erueca mide, olea mide, and processing aids; and fumed, precipitated, and amorphous silica. The company serves paints and coatings, inks and pigments, plastics and polymer, paper, rubber, cosmetics, ceramics, adhesive and sealant, oil-well drilling, agrochemicals, foundry, and other industries. It also exports its products. The company was incorporated in 1987 and is headquartered in Vadodara, India.
How the Company Makes Money20 Microns Limited primarily makes money by manufacturing and selling micronized and surface-treated mineral products (industrial mineral powders and functional fillers/additives) to business customers. Its core revenue stream is product sales, where pricing and volumes are driven by demand from downstream industries (e.g., paints/coatings, plastics, rubber, paper, construction) that use these minerals to improve performance and/or reduce formulation costs. Earnings are influenced by its ability to (a) produce consistent particle-size and performance specifications, (b) provide application-focused grades (including value-added treated/engineered variants that typically command better realizations than commodity minerals), and (c) maintain distribution/supply relationships with industrial customers that purchase on repeat, specification-based demand. Specific details on significant partnerships and the exact split of revenue by product line or customer segment are null.

20 Microns Limited Financial Statement Overview

Summary
Strong income statement performance (revenue growth and high gross/EBIT margins) and a solid balance sheet (manageable leverage and healthy equity base) are partly offset by weaker cash flow quality, with significantly lower free cash flow and only moderate cash conversion.
Income Statement
85
Very Positive
20 Microns Limited has shown strong revenue growth with a notable increase from the previous year, indicating a positive trajectory. The company has consistently improved its gross profit margin, reaching 46.97% in the most recent year. The EBIT margin is also robust at 38.78%, reflecting effective operational management. However, the EBITDA margin of 13.21% suggests potential areas for operational efficiency improvements. Overall, the income statement metrics highlight strong profitability and growth, though there's room for optimizing EBITDA.
Balance Sheet
78
Positive
The balance sheet of 20 Microns Limited is stable with a favorable debt-to-equity ratio of 0.39, indicating prudent leverage management. The return on equity (ROE) is impressive at 14.53%, showcasing effective use of equity capital. The equity ratio stands at 60.09%, highlighting a strong equity base relative to total assets. Despite these strengths, the company should remain vigilant about debt management to maintain financial stability.
Cash Flow
60
Neutral
The cash flow statement reveals some challenges, as the free cash flow has decreased significantly, resulting in negative free cash flow growth. The operating cash flow to net income ratio is 0.51, indicating moderate cash conversion from earnings. The free cash flow to net income ratio is negative due to substantial capital expenditures, suggesting the need for careful capital investment planning. Overall, while the operating cash flow remains positive, the cash flow position could be improved with more efficient capital allocation.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue9.20B9.17B7.76B7.02B6.11B4.83B
Gross Profit3.98B4.31B2.77B3.24B2.20B1.64B
EBITDA1.22B1.21B994.95M886.70M815.54M607.63M
Net Income623.61M623.76M560.70M418.19M345.85M229.72M
Balance Sheet
Total Assets7.42B7.15B5.90B4.60B5.15B4.52B
Cash, Cash Equivalents and Short-Term Investments583.46M393.96M606.82M299.41M168.49M40.62M
Total Debt1.63B1.66B1.22B1.08B1.23B1.04B
Total Liabilities2.83B2.80B2.36B1.91B2.63B2.37B
Stockholders Equity4.55B4.29B3.53B2.94B2.51B2.14B
Cash Flow
Free Cash Flow367.06M-448.94M345.62M507.09M79.27M415.86M
Operating Cash Flow524.39M317.86M544.43M631.97M353.20M520.48M
Investing Cash Flow-193.56M-632.56M-204.69M-176.74M-231.72M-91.26M
Financing Cash Flow-150.13M140.21M-55.10M-379.73M-36.04M-452.65M

20 Microns Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price198.45
Price Trends
50DMA
180.19
Negative
100DMA
189.81
Negative
200DMA
209.90
Negative
Market Momentum
MACD
-6.24
Positive
RSI
26.44
Positive
STOCH
9.49
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:20MICRONS, the sentiment is Negative. The current price of 198.45 is above the 20-day moving average (MA) of 171.69, above the 50-day MA of 180.19, and below the 200-day MA of 209.90, indicating a bearish trend. The MACD of -6.24 indicates Positive momentum. The RSI at 26.44 is Positive, neither overbought nor oversold. The STOCH value of 9.49 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:20MICRONS.

20 Microns Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
₹9.84B17.660.52%28.67%50.12%
63
Neutral
₹7.80B24.500.38%12.35%6.79%
62
Neutral
₹5.42B12.550.63%7.23%5.00%
62
Neutral
₹4.77B9.3267.43%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
₹5.49B697.5115.56%2114.71%
57
Neutral
₹3.97B51.210.13%13.17%-0.02%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:20MICRONS
20 Microns Limited
153.60
-42.12
-21.52%
IN:BODALCHEM
Bodal Chemicals Limited
43.60
-16.40
-27.33%
IN:INDOBORAX
Indo Borax & Chemicals Limited
243.05
70.78
41.09%
IN:KHAICHEM
Khaitan Chemicals & Fertilizers Ltd.
49.22
0.40
0.82%
IN:SHIVALIK
Shivalik Rasayan Ltd
251.95
-324.90
-56.32%
IN:SHREEPUSHK
Shree Pushkar Chemicals & Fertilisers Ltd.
304.30
13.99
4.82%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 17, 2026